News

GEN - Genetic Engineering and Biotechnology News1d
PEG Alternative Minimizes Immunogenicity from LNP-Based Therapies
Replacing PEG with PCB in lipid nanoparticles led to potent mRNA vaccines that avoided unwanted immune responses.
'Stealthy' lipid nanoparticles give mRNA vaccines a makeover
A new material developed at Cornell University could significantly improve the delivery and effectiveness of mRNA vaccines by ...
News-Medical.Net on MSN1d
New material could improve delivery and effectiveness of mRNA vaccines
A new material developed at Cornell University could significantly improve the delivery and effectiveness of mRNA vaccines by ...
pharmaphorum2d
Taking an ‘upside-down’ approach to mRNA delivery
There are a variety of mRNA delivery methods that have been developed in an attempt to navigate the challenges, such as direct injection of naked mRNA, lipid-based carriers, polymers, and protein ...
Aphios Receives U.S. Patent Allowance for Groundbreaking Room Temperature-Stable, Single-Shot mRNA COVID-19 Vaccine
Aphios has received a patent allowance for a single-dose, room temp-stable mRNA COVID-19 vaccine. No cold chain. No PEG. Just sustained protection.
Beam Therapeutics Announces U.S. FDA Orphan Drug Designation Granted to BEAM-302 for the Treatment of Alpha-1 Antitrypsin Deficiency (AATD)
Detailed price information for Beam Therapeutics Inc (BEAM-Q) from The Globe and Mail including charting and trades.